What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Interview Jul 19, 2024
Expanding the Alimentiv Site Network: An Interview With Peter Westerveld

The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring…

Publication Dec 9, 2023
Use of external control arms in immune-mediated inflammatory diseases: a systematic review
Publication Dec 3, 2023
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn’s Disease Activity
Publication Nov 24, 2023
Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Publication Oct 10, 2023
Case Report: Medical Management of Acute Severe Ulcerative Colitis
Publication Sep 11, 2023
Standardizing Randomized Controlled Trials in Celiac Disease: An International Multidisciplinary Appropriateness Study
Publication Aug 17, 2023
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis